Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Catalyst Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Catalyst Pharmaceuticals Inc
Rating: 3.02404175
Author: Trendlyne DVM scores

Strong Performer, Under Radar

about

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

23.93 -0.52 (-2.13%)

25.62% Gain from 52W Low

319.1K

XNAS Volume

XNAS 23 Jan, 2026 12:29 PM (EST)

High Financial Strength

66.7 / 100

Affordable Valuation

52.0 / 100

Technically Neutral

56.6 / 100

Strong Performer, Under Radar These stocks have good quality scores and strong financials. They are affordably priced stocks with potential for good returns View Similar Embed DVM

1Yr Price target upside is 46%

7 analysts

Catalyst Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

25.62% Gain from 52W Low

SWOT Analysis

Catalyst Pharma Inc Live Price Chart